UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038603
Receipt number R000043698
Scientific Title The persistence of fesoterodine and the reasons for withdrawal from treatment of treatment-naive female patients with overactive bladder in the real-world clinical setting
Date of disclosure of the study information 2019/11/17
Last modified on 2020/05/17 23:17:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The persistence of fesoterodine and the reasons for withdrawal from treatment of treatment-naive female patients with overactive bladder in the real-world clinical setting

Acronym

Persistence and reasons for withdrawal of fesoterodine

Scientific Title

The persistence of fesoterodine and the reasons for withdrawal from treatment of treatment-naive female patients with overactive bladder in the real-world clinical setting

Scientific Title:Acronym

Persistence and reasons for withdrawal of fesoterodine

Region

Japan


Condition

Condition

Overactive bladder

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The persistence of treatment with fesoterodine and the reasons for withdrawal from the treatment among treatment-naive female patients with overactive bladder were prospectively investigated in the real-world clinical setting

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The persistence of treatment with fesoterodine and the reasons for withdrawal from the treatment

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Treatment-naive Japanese female patients who visited the hospital for the symptoms of OAB and were clinically diagnosed with OAB

Key exclusion criteria

Patients with urinary tract infection, large postvoid residual volume, a previous treatment history for OAB, and contraindications to use of fesoterodine

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yoshinori
Middle name
Last name Tanaka

Organization

Hokkaido Prefectural Esashi Hospital

Division name

Division of Urology

Zip code

043-0022

Address

484, Fushikido-cho, Esashi-cho, Hiyama-gun, Hokkaido 043-0022, Japan

TEL

0139-52-0036

Email

rinoshiyokanata@me.com


Public contact

Name of contact person

1st name Yoshinori
Middle name
Last name Tanaka

Organization

Hokkaido Prefectural Esashi Hospital

Division name

Division of Urology

Zip code

043-0022

Address

484, Fushikido-cho, Esashi-cho, Hiyama-gun, Hokkaido 043-0022, Japan

TEL

0139-52-0036

Homepage URL


Email

rinoshiyokanata@me.com


Sponsor or person

Institute

Hokkaido Prefectural Esashi Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Hokkaido Prefectural Esashi Hospital

Address

484, Fushikido-cho, Esashi-cho, Hiyama-gun, Hokkaido 043-0022, Japan

Tel

0139-52-0036

Email

hofuku.esabyo2@pref.hokkaido.jg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 09 Month 26 Day

Date of IRB

2014 Year 09 Month 26 Day

Anticipated trial start date

2014 Year 10 Month 01 Day

Last follow-up date

2024 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 11 Month 16 Day

Last modified on

2020 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043698


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name